As of August 04, 2026, Lantern Pharma's top three insider holders are Aaron G.L. Fletcher (TenPercentOwner, 1.17Mn shares), Leslie W. Kreis (TenPercentOwner, 1.05Mn shares), Leslie W. Kreis (Director, 893.94K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Aaron G.L. Fletcher | - | 0 | 1,168,485 | 13 Jun, 2025 |
| Leslie W. Kreis | - | 0 | 1,049,859 | 13 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Jan, 2026 | Lee Troy Schalop | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | David S. Silberstein | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | Lee Troy Schalop | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | David S. Silberstein | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | David S. Silberstein | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | Vijay Chandru | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | Maria-Luisa Maccecchini | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | Lee Troy Schalop | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | Maria-Luisa Maccecchini | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | D Jeffrey Keyser | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | Maria-Luisa Maccecchini | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 09 Jan, 2026 | Lee Troy Schalop | Stock Option (Right to Buy) | A | 18,460 | $0.00 | 18,460 | D | A |
| 09 Jan, 2026 | David S. Silberstein | Stock Option (Right to Buy) | A | 17,307 | $0.00 | 17,307 | D | A |
| 09 Jan, 2026 | Vijay Chandru | Stock Option (Right to Buy) | A | 17,307 | $0.00 | 17,307 | D | A |
| 09 Jan, 2026 | Lee Troy Schalop | Stock Option (Right to Buy) | A | 18,460 | $0.00 | 18,460 | D | A |
| 09 Jan, 2026 | D Jeffrey Keyser | Stock Option (Right to Buy) | A | 28,844 | $0.00 | 28,844 | D | A |
| 09 Jan, 2026 | David S. Silberstein | Stock Option (Right to Buy) | A | 17,307 | $0.00 | 17,307 | D | A |
| 09 Jan, 2026 | Maria-Luisa Maccecchini | Stock Option (Right to Buy) | A | 21,152 | $0.00 | 21,152 | D | A |
| 09 Jan, 2026 | Lee Troy Schalop | Stock Option (Right to Buy) | A | 18,460 | $0.00 | 18,460 | D | A |
| 09 Jan, 2026 | Maria-Luisa Maccecchini | Stock Option (Right to Buy) | A | 21,152 | $0.00 | 21,152 | D | A |